m+Medelevator.RU
← Поиск публикаций
iScience · 2026

Deep-learning-based artificial intelligence approaches for grading and progression prediction of clear cell renal cell carcinoma.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhou Jing, Su BoJin, Zhao Chang, Huang QunXiong, Cheng Na, Di JinMing, Gu JianXiong, Liu Hailing, Liang Qiong, Hui DaYang, Weng ZiJin, Tang LuYing, Yang RiHong, Han LanQing, Chen JianNing, Ren Yong, Shao ChunKui

Аннотация

The grading classification of clear cell renal cell carcinoma (CCRCC) is a crucial prognostic factor. However, manual observation can lead to subjective and inconsistent diagnoses. In this study, we aimed to develop a deep-learning-based grading system for CCRCC using whole-slide image (WSI) and to predict disease progression. A total of 305 CCRCC cases were used to develop the renal cell carcinoma artificial intelligence diagnosis (RCCAID) model for grading (188 training, 47 verification, and 70 testing cases) and the renal cell carcinoma artificial intelligence prognostic (RCCAIP) progression prediction model (288 cases). Progression was defined as the presence of distant and/or lymph node metastasis. Xception, ResNet50, and Inception V3 were employed. Model performance was assessed via confusion matrix, receiver operator characteristic curve (ROC) curve, and classification map. RCCAID achieved area under the curve (AUC) values of 0.987 (internal), 0.996 (in-house), and 0.967 (external). The quadratic weighted Cohen's kappa was 0.864, comparable to senior pathologists (0.871). RCCAIP achieved an AUC of 0.94 for progression prediction. Higher grades correlated with worse prognosis. RCCAID can accurately grade CCRCC in whole-slide images, and RCCAIP is effective in progression prediction, even for low-grade tumors.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты